Overcoming TGFβ-mediated immune evasion in cancer

DVF Tauriello, E Sancho, E Batlle - Nature Reviews Cancer, 2022 - nature.com
Transforming growth factor-β (TGFβ) signalling controls multiple cell fate decisions during
development and tissue homeostasis; hence, dysregulation of this pathway can drive …

Targeting TGFβ signal transduction for cancer therapy

S Liu, J Ren, P Ten Dijke - Signal transduction and targeted therapy, 2021 - nature.com
Transforming growth factor-β (TGFβ) family members are structurally and functionally related
cytokines that have diverse effects on the regulation of cell fate during embryonic …

The pharmacology of second-generation chimeric antigen receptors

SJC Van Der Stegen, M Hamieh… - Nature reviews Drug …, 2015 - nature.com
Second-generation chimeric antigen receptors (CARs) retarget and reprogramme T cells to
augment their antitumour efficacy. The combined activating and co-stimulatory domains …

Mesothelin-targeted CARs: driving T cells to solid tumors

A Morello, M Sadelain, PS Adusumilli - Cancer discovery, 2016 - AACR
Chimeric antigen receptors (CAR) are synthetic receptors that target T cells to cell-surface
antigens and augment T-cell function and persistence. Mesothelin is a cell-surface antigen …

Multiple signaling roles of CD3ε and its application in CAR-T cell therapy

W Wu, Q Zhou, T Masubuchi, X Shi, H Li, X Xu… - Cell, 2020 - cell.com
AT cell receptor (TCR) mediates antigen-induced signaling through its associated CD3ε, δ,
γ, and ζ, but the contributions of different CD3 chains remain elusive. Using quantitative …

Neuroblastoma: developmental biology, cancer genomics and immunotherapy

NKV Cheung, MA Dyer - Nature Reviews Cancer, 2013 - nature.com
Neuroblastoma is a solid tumour that arises from the developing sympathetic nervous
system. Over the past decade, our understanding of this disease has advanced …

Design and development of therapies using chimeric antigen receptor‐expressing T cells

G Dotti, S Gottschalk, B Savoldo… - Immunological …, 2014 - Wiley Online Library
Investigators developed chimeric antigen receptors (CAR s) for expression on T cells more
than 25 years ago. When the CAR is derived from an antibody, the resultant cell should …

Gene-engineered T cells for cancer therapy

MH Kershaw, JA Westwood, PK Darcy - Nature Reviews Cancer, 2013 - nature.com
T cells have the capacity to eradicate diseased cells, but tumours present considerable
challenges that render T cells ineffectual. Cancer cells often make themselves …

Multifactorial T-cell hypofunction that is reversible can limit the efficacy of chimeric antigen receptor–transduced human T cells in solid tumors

EK Moon, LC Wang, DV Dolfi, CB Wilson… - Clinical cancer …, 2014 - AACR
Purpose: Immunotherapy using vaccines or adoptively transferred tumor-infiltrating
lymphocytes (TIL) is limited by T-cell functional inactivation within the solid tumor …

Induction of tumor cell autosis by myxoma virus-infected CAR-T and TCR-T cells to overcome primary and acquired resistance

N Zheng, J Fang, G Xue, Z Wang, X Li, M Zhou, G Jin… - Cancer Cell, 2022 - cell.com
Cytotoxicity of tumor-specific T cells requires tumor cell-to-T cell contact-dependent
induction of classic tumor cell apoptosis and pyroptosis. However, this may not trigger …